NSPR
InspireMD, Inc.
NASDAQ · Healthcare · Medical - Devices · IL
$0.44
−3.34%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.46
From 52W high−81.28%
Volume122501.00
Market cap$20.46M
P/E (TTM)—
P/S (TTM)1.9x
Div yield—
Key dataOct 19, 2026
Open
$0.46
From 52W high
−81.28%
Volume
122501.00
Market cap
$20.46M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
P/E (TTM)
—
RSI (14)
24.9
MomentumView details →
1D Return
−3.34%
YTD Return
−74.33%
SummaryUpdated Jun 1, 2026
InspireMD, Inc. (NASDAQ:NSPR) is an Israeli medical device company founded in 2005 and headquartered in Tel Aviv-Yafo, Israel. The company specializes in developing and commercializing proprietary MicroNet stent platform technology for treating vascular and coronary diseases. InspireMD has been publicly traded since 2011 and operates primarily in international markets including Europe, Latin America, the Middle East, and Asia Pacific through local distributors. The company is currently preparing for its most significant milestone - entering the U.S. market with FDA approval expected for its flagship CGuard Prime system in 2025.
Similar companies
Latest newsMore news →
InspireMD amended certain Series J and Series K warrants, potentially raising up to $11 million in gross proceeds, with the amendments aligning the warrants' trigger event to the anticipated FDA approval of CGuard Prime 80 cm.29d agoInspireMD, Inc. reported a Q2 2026 net loss of $0.17 per share, beating the Zacks Consensus Estimate of a $0.20 loss and improving from a $0.26 loss a year earlier.66d ago